MEDICIS PHARMACEUTICAL CORP 4

Accession 0001246360-12-004836

CIK 0000859368operating

View on SEC.gov Company Profile

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 3:55 PM ET

Size

27.6 KB

Accession

0001246360-12-004836

Insider Transaction Report

Form 4

Period: 2012-12-11

MEDICIS PHARMACEUTICAL CORPMRX

ALTSCHUL ARTHUR G JR

Director

Transactions

Disposition to Issuer
Non-Employee Director Option
2012-12-11$21.21/sh−15,000$318,150→ 0 total
Exercise: $22.79Exp: 2015-05-20→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$11.65/sh−7,500$87,375→ 0 total
Exercise: $32.35Exp: 2013-09-29→ Common Stock (7,500 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$4.96/sh−21,000$104,160→ 0 total
Exercise: $39.04Exp: 2014-09-30→ Common Stock (21,000 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$10.19/sh−15,000$152,850→ 0 total
Exercise: $33.81Exp: 2014-05-22→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$11.44/sh−15,000$171,600→ 0 total
Exercise: $32.56Exp: 2015-09-30→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$14.70/sh−21,000$308,700→ 0 total
Exercise: $29.30Exp: 2013-09-30→ Common Stock (21,000 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$7.71/sh−6,842$52,752→ 0 total
Exercise: $36.29Exp: 2018-05-17→ Common Stock (6,842 underlying)
Disposition to Issuer
Common Stock
2012-12-11$44.00/sh−8,497$373,868→ 0 total
Disposition to Issuer
Non-Employee Director Option
2012-12-11$6.15/sh−7,743$47,619→ 0 total
Exercise: $37.85Exp: 2019-05-15→ Common Stock (7,743 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$20.38/sh−15,000$305,700→ 0 total
Exercise: $23.62Exp: 2017-05-18→ Common Stock (15,000 underlying)
Disposition to Issuer
Non-Employee Director Option
2012-12-11$28.11/sh−5,545$155,870→ 0 total
Exercise: $15.89Exp: 2016-05-19→ Common Stock (15,000 underlying)

Footnotes (3)

[F1]On December 11, 2012, the Issuer completed its merger (the "Merger") with Valeant Pharmaceuticals International ("Valeant"), whereby the Issuer became a wholly owned subsidiary of Valeant, pursuant to an Agreement and Plan of Merger that was entered into on September 2, 2012 (the "Merger Agreement"). In accordance with the Merger Agreement, each share of common stock of the Issuer issued and outstanding immediately prior to the consummation of the Merger converted into a right to receive an amount in cash equal to $44.00 per share (the "Per Share Merger Consideration"), without interest. The amount of shares in Column 4 includes 2,311 restricted shares of common stock that also converted into a right to receive the Per Share Merger Consideration.
[F2]In accordance with the terms of the Merger Agreement, each option to acquire shares of the Issuer (whether vested or unvested) that was outstanding immediately prior to the consummation of the Merger was cancelled in exchange for the right to receive an amount in cash equal to the product of the number of shares of Issuer common stock subject to the option and the excess, if any, of the Per Share Merger Consideration over the exercise price per share of each respective award, less any required withholding taxes. This award had fully vested prior to the consummation of the Merger.
[F3]In accordance with the terms of the Merger Agreement, each option to acquire shares of the Issuer (whether vested or unvested) that was outstanding immediately prior to the consummation of the Merger was cancelled in exchange for the right to receive an amount in cash equal to the product of the number of shares of Issuer common stock subject to the option and the excess, if any, of the Per Share Merger Consideration over the exercise price per share of each respective award, less any required withholding taxes. This award was fully unvested prior to the consummation of the Merger.

Documents

1 file

4
form.xmlPrimary
PRIMARY DOCUMENT

Issuer

MEDICIS PHARMACEUTICAL CORP

CIK 0000859368

→

Entity typeoperating

IncorporatedDE

Related Parties

filerCIK 0000859368

Filing Metadata

Form type: 4
Filed: Dec 12, 7:00 PM ET
Accepted: Dec 13, 3:55 PM ET
Size: 27.6 KB

View on SEC.gov